Characterizing the cross-sectional approach to Ovarian cancer: Genetic testing of BRCA

Trial Identifier: D0816R00013
Sponsor: AstraZeneca
NCTID:: NCT03229122
Start Date: December 2016
Primary Completion Date: July 2018
Study Completion Date: July 2018
Condition: Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aichi, Japan
Japan Akita, Japan
Japan Aomori, Japan
Japan Chiba, Japan
Japan Fukuoka, Japan
Japan Fukushima, Japan
Japan Gifu, Japan
Japan Hyogo, Japan
Japan Ibaraki, Japan
Japan Izumo, Japan
Japan Kanagawa, Japan
Japan Kumamoto, Japan
Japan Kyoto, Japan
Japan Maebashi, Japan
Japan Matsuyama, Japan
Japan Mie, Japan
Japan Miyagi, Japan
Japan Morioka, Japan
Japan Nagano, Japan
Japan Nagasaki, Japan
Japan Nara, Japan
Japan Niigata, Japan
Japan Okayama, Japan
Japan Okinawa, Japan
Japan Osaka, Japan
Japan Saga, Japan
Japan Saitama, Japan
Japan Sapporo, Japan
Japan Sendai, Japan
Japan Tochigi, Japan
Japan Tokushima, Japan
Japan Tokyo, Japan
Japan Toon, Japan
Japan Tottori, Japan
Japan Yamagata, Japan